Pune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine – The Indian Express

1. Pune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine  The Indian Express
2. AI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses  CEPI
3. Gennova Biopharma partners with CEPI to develop mRNA Nipah vaccine  Business Standard
4. $13.38 Million Funds saRNA Nipah Virus Vaccine Candidate Development  Vax-Before-Travel
5. Gennova Biopharma accelerates development of Nipah virus vaccines using mRNA technology  BioSpectrum India

 Pune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine  The Indian ExpressAI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses  CEPIGennova Biopharma partners with CEPI to develop mRNA Nipah vaccine  Business Standard$13.38 Million Funds saRNA Nipah Virus Vaccine Candidate Development  Vax-Before-TravelGennova Biopharma accelerates development of Nipah virus vaccines using mRNA technology  BioSpectrum India  Top stories – Google News